Micrus added to Neurotech Index
Micrus Endovascular (San Jose, California) said that it has been added to the newly formed Nasdaq NeuroInsights Neurotech Index, launched Sept. 25. The Nasdaq stock market and NeuroInsights, a research firm that focuses on neurotechnology, partnered to create the index, which is disseminated under the symbol "NERV."
The NeuroInsights Neurotech Index is a pure-play modified market capitalization-weighted index designed to track the performance of the largest and most liquid neurotechnology companies that are listed and actively traded on one of the three major U.S. stock exchanges.
The Index is designed to track the performance of publicly traded companies researching, developing, manufacturing and marketing pharmaceuticals, biologics, medical devices and diagnostics for the brain and nervous system.
Index companies are defined by NeuroInsights as significantly involved in neurotechnology and must meet market criteria including a $200 million market capitalization and a three-month average daily trading volume of 100,000 shares.
Sagemark forms subsidiary
The Sagemark Companies (New York) said that it has formed Premier Oncology, a wholly owned subsidiary, to pursue its radiation therapy cancer treatment center initiative.
Premier Oncology's first radiation therapy venture is Premier Oncology Management of Nassau, which is developing a 5,000 square foot out-patient cancer treatment facility in Great Neck, New York, that will feature a TomoTherapy Hi-Art system, one of the most advanced radiation therapy cancer treatment systems available, with an anticipated opening in Q108.
The location of the Great Neck center will build on the company's existing presence in that market, where for the past five years, it has built a substantial referring physician base for its PET/CT imaging centers — two of which are located within the referring physician radius of the new radiation therapy center.
The Sagemark Companies owns, operates and administers out-patient medical diagnostic imaging centers that utilize positron emission tomography (PET), and PET and computed tomography (PET/CT) equipment.